KTE-X19 for treating relapsed or refractory mantle cell lymphoma: Evidence Review Group Report for the National Institute for Health and Care Excellence

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherNational Institute for Health and Care Excellence
Commissioning bodyNational Institute for Health and Care Excellence
Publication statusPublished - 2020

Cite this